Jim D'Augustine

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA

Part of Avancen MOD Corp., Avancen, Inc. manufactures industrial rubber goods, rubberized fabrics, and miscellaneous rubber specialties. The company is based in Palm Coast, FL.

NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA.

Magnolia Medical Technologies, Inc. develops medical devices that focus on improving the accuracy of diagnostic blood culture tests. The company was founded by Gregory J. Bullington and Richard G. Patton and is headquartered in Seattle, WA.

Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Daum GmbH & Co. KG is a German company that specializes in textile finishing services such as embroidery, laser branding, and transfer printing. The private company was founded in 2002 and is based in Trautskirchen, Germany. The company offers full-service solutions and fast project processing with a focus on high-quality results.

Dune Medical Devices Ltd. engages in the development of real-time cancer detection tools. Its products are MarginProbe and Smart Biopsy System. The company was founded by Dan Hashimshony in 2002 and is headquartered in Caesarea, Israel.

Cardiva Medical, Inc. designs and develops vascular access management products. It offers VASCADE, an extravascular closure device designed to increase the comfort and safety of vascular closure for patients; and Catalyst, a device that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition and coagulation. The company was founded by Zia Yassinzadeh and Augustine Y. Lien in July 2002 and is headquartered in Santa Clara, CA.

Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC.

Trident Labs, Inc. engages in the operation of toxicology laboratories. It offers urine and oral fluid drug testing to help medical offices monitor adherence to prescription medication and abstinence from illicit drugs. The company is headquartered in Holland, MI.

AH Capital Management LLC (AH Capital Management) is a venture capital firm founded in 2009 by Marc Lowell Andreessen and Ben A. Horowitz. The firm is headquartered in Menlo Park, California.

twoXAR, Inc. provides drug discovery services. Its DUMA platform rapidly evaluates massive public and proprietary datasets to identify and rank probability drug-disease matches. The company was founded by Andrew A. Radin and Andrew M. Radin in 2014 and is headquartered in Palo Alto, CA.

Dyno Therapeutics, Inc. engages in the development of therapeutics technologies. It develops technologies for safe, efficient and targeted in vivo delivery of new gene therapies and genome editing therapies. The company was founded by Kelsic Eric David and is headquartered in Watertown, MA.

Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom.

Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.

Komodo Health, Inc. provides modern healthcare intelligence. The firm provides data engineering, life sciences, predictive analytics, healthcare, professional services, and machine intelligence. The company was founded by Web Sun and Arif Nathoo in 2014 and is headquartered in San Francisco, CA.

Asimov, Inc. develops and operates software platform for biotechnology. Its platform combines computer-aided design, artificial intelligence, and synthetic biology. The company was founded by Christopher Voigt, Douglas Densmore, Alec Neilson, and Raja Srinivas on March 27, 2017 and is headquartered in Cambridge, MA.

IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation.

Evidity Capital LLC (Evidity Capital) is a venture capital firm founded in 2014 by Paul Enever and Alejandro Sanchez. The firm is headquartered in New York.

Edifice Health, Inc. is a digital health spin-out company that offers a novel metric of inflammatory health, which is augmented with personalized health interventions to improve and extend healthspan. The company is based in San Mateo, CA. The company has solid underpinnings in immunological science and AI-powered technology. Edifice Health aims to tackle chronic diseases worldwide with a consumer and market-centric orientation. The company was founded by Mark M. Davis and David Furman.